2042

antibody from Cell Signaling Technology, Inc

Targeting: XIAP API3, BIRC4, hILP, ILP-1

Western blot (Data presented on provider website)

Antibody Data

Product number

2042

Provider

Cell Signaling Technology, Inc

Proper citation

Cell Signaling Technology Cat#2042, RRID:AB_2214870

Product name

XIAP Antibody

Antibody type

Polyclonal

Reactivity

Human, Mouse, Rat, Simian

Host

Rabbit

Storage

-20°C

References

Submitted references

Bortezomib sensitizes malignant human glioma cells to TRAIL, mediated by inhibition of the NF-{kappa}B signaling pathway.

Jane EP, Premkumar DR, Pollack IF
Molecular cancer therapeutics 2011 Jan;10(1):198-208

---

XIAP gene expression and function is regulated by autocrine and paracrine TGF-beta signaling.

Van Themsche C, Chaudhry P, Leblanc V, Parent S, Asselin E
Molecular cancer 2010 Aug 16;9:216

---

Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells.

Rosato RR, Almenara JA, Dai Y, Grant S
Molecular cancer therapeutics 2003 Dec;2(12):1273-84

---

Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis.

Guégan C, Vila M, Rosoklija G, Hays AP, Przedborski S
The Journal of neuroscience : the official journal of the Society for Neuroscience 2001 Sep 1;21(17):6569-76